Two drug companies had a bad week. AstraZeneca (AZN) lost 12.06% last week, while Moderna (MRNA) fell by 14.41%. AZN stock ...

The University of Oxford has launched what it says is the world's first phase I clinical trial of a vaccine specifically ...

ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ ...

The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.

The small Ugandan city of Masaka is known mostly for its coffee, grown on rich volcanic soils that produce beans which have a ...

A longevity gene therapy targeting the molecular mechanism behind why some people live to 100 has maintained its early benefits three months after dosing aged beagles — and the Vancouver firm whose ...

Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, ...

Health Minister Budi Gunadi Sadikin sets a target for Indonesia to domestically manufacture all 15 vaccine antigens used in ...

MRK trades above its 50- and 200-day SMAs as pipeline progress, acquisitions and Keytruda strength offset patent and vaccine ...